Articles for category: Most Popular

The whipping post

Most Popular

Unveiling the Securities Fraud Allegations Against Outset Medical Unveiling the Securities Fraud Allegations Against Outset Medical

LOS ANGELES, Sept. 20, 2024 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have an opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM. Class Period: August 1, 2022 – August 7, 2024 Lead Plaintiff Deadline: October 28, ...

The whipping post

Most Popular

The Bright Prospects of Vertiv Stock as a Long-Term Investment in the AI Sector

Vertiv’s Position in AI and Big Data Vertiv is a steadfast player in the field of artificial intelligence (AI), backed by partnerships with industry leader Nvidia. The company’s innovative solutions and services in power, cooling, and IT infrastructure support critical operations in data centers and communication networks. Spanning various sectors like healthcare, retail, telecom, and ...

The whipping post

Most Popular

Decoding the Options Market Trends Surrounding Caterpillar Decoding the Options Market Trends Surrounding Caterpillar

When deep-pocketed investors start playing the bullish tune on a stock like Caterpillar, it’s akin to a bat signal lighting up the financial skyline. It’s a signal that should make even the most steadfast market spectator perk up with attention. And when the team at Benzinga teases out this pivotal move from the shadows, the ...

The whipping post

Most Popular

Alibaba Surges with AIDC Strength: Investor Insights Alibaba Surges with AIDC Strength: Investor Insights

Alibaba BABA has demonstrated an impressive gain of 13.6% over the last three months, outshining the Zacks Internet-Commerce industry’s modest 3.6% return, the Retail-Wholesale sector’s 4.6% rise, and the S&P 500’s 2.6% rally. The driving force behind this surge lies in the Alibaba International Digital Commerce Group (AIDC), encompassing Lazada, AliExpress, Trendyol, Alibaba.com, and several ...

The whipping post

Most Popular

Tesla’s Chargers Spark Up Amidst Electric Vehicle Market Upsurge

The electric vehicle (EV) landscape has hit a rough patch recently, with sales momentum in the U.S. slowing down, Chinese EVs seeking global market penetration, and a lackluster charging infrastructure in various regions. Unquestionably, Tesla (NASDAQ: TSLA) has been grappling with its fair share of challenges. However, amidst this cloud of adversity, some rays of ...

The whipping post

Most Popular

Investing Insights Post-Fed Rate Cut Unlocking Opportunities: Navigating the Post-Fed Rate Cut Terrain

In a pivotal move on Wednesday, the Federal Reserve opted for an outsized 50-basis point rate cut, a decision typically reserved for times of economic turmoil. Fed Chair Jerome Powell’s strategic shift in policy focus from inflation to the labor market set tongues wagging in financial circles. The central bank’s forward guidance signals a path ...

The whipping post

Most Popular

Evaluating Amazon.com, Inc.’s Attractive Investment Potential

Amazon (AMZN) recently grabbed investors’ attention as one of the most searched stocks on Zacks.com. Exploring the critical factors that can impact its performance in the near future is imperative for savvy investors. Over the past month, this online retail giant’s shares surged by +7.8%, surpassing the Zacks S&P 500 composite’s +2.1% change. Within the ...

The whipping post

Most Popular

Vanda Pharmaceuticals Faces Setback as FDA Rejects NDA for Tradipitant in Gastroparesis Vanda Pharmaceuticals Faces Setback as FDA Rejects NDA for Tradipitant in Gastroparesis

Vanda Pharmaceuticals Inc. VNDA recently experienced a dip in its stock price after receiving a complete response letter from the FDA regarding its new drug application (NDA) for tradipitant, a potential treatment for gastroparesis. The announcement led to a 6.1% decrease in the company’s shares on Sept. 19, highlighting the regulatory setback. Gastroparesis, characterized by ...